HomeStock ScreenerSamsrita LabsIntrinsic Value

Samsrita Labs Intrinsic Value

Samsrita Labs (SAMSRITA) median intrinsic value is ₹5.22 from 1 valuation models (range ₹5–₹5), vs current price ₹12.35 — -57.7% downside (Trading Above Calculated Value), margin of safety -100.0%. Analyse SAMSRITA shareholding pattern to track promoter, FII and institutional holdings.

Current Stock Price
₹12.35
Primary Intrinsic Value
₹5.22
Market Cap
₹28.4 Cr
-57.7% Downside
Median Value
₹5.22
Value Range
₹5 - ₹5
Assessment
Trading Above Calculated Value
Safety Margin
-100.0%

SAMSRITA Valuation Methods Summary — DCF, Graham Number & P/E

Samsrita Labs intrinsic value across 1 models vs current price ₹12.35 — upside/downside and value range per method. Read SAMSRITA dividend payout details for the complete payout history and dividend yield track record.

Method Type Intrinsic Value Range Upside/Downside Details
Book Value Method asset ₹5.22 ₹4.70 - ₹5.74 -57.7% Book Value/Share: ₹5.22, P/B: 1.0x
Method Types: Earnings Asset DCF Growth Dividend Conservative

SAMSRITA Intrinsic Value vs Market Price — All Valuation Models

Samsrita Labs fair value range ₹5–₹5 vs current market price ₹12.35 across 1 valuation models. For current market price and key ratios, visit Samsrita Labs share price screener.

SAMSRITA Intrinsic Value Analysis — Undervalued or Overvalued?

Samsrita Labs median intrinsic value ₹5.22, current price ₹12.35 — Trading Above Calculated Value by 57.7%, margin of safety -100.0%.

What is the intrinsic value of SAMSRITA?

Based on our comprehensive analysis using 1 different valuation methods, the estimated intrinsic value of Samsrita Labs (SAMSRITA) is ₹5.22 (median value). With the current market price of ₹12.35, this represents a -57.7% variance from our estimated fair value.

The valuation range spans from ₹5.22 to ₹5.22, indicating ₹5.22 - ₹5.22.

Is SAMSRITA undervalued or overvalued?

Based on our multi-method analysis, Samsrita Labs (SAMSRITA) appears to be trading above calculated value by approximately 57.7%.

SAMSRITA Financial Health — Key Ratios vs Industry Benchmarks

Samsrita Labs financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Return on Equity -33.3% Industry Standard: 15%+ Below 10% Measures shareholder return efficiency
Operating Margin -750.0% Industry Standard: 20%+ Below 10% Indicates operational efficiency level

SAMSRITA Cash Flow Quality — Operating & Free Cash Flow

Samsrita Labs operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2025 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2024 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2023 ₹1 Cr ₹1 Cr Positive Free Cash Flow 8/10
March 2022 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2021 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10